Ciara M. Kelly

7.5k total citations · 1 hit paper
64 papers, 1.1k citations indexed

About

Ciara M. Kelly is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Immunology. According to data from OpenAlex, Ciara M. Kelly has authored 64 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 41 papers in Pulmonary and Respiratory Medicine, 40 papers in Oncology and 10 papers in Immunology. Recurrent topics in Ciara M. Kelly's work include Sarcoma Diagnosis and Treatment (22 papers), CAR-T cell therapy research (15 papers) and Vascular Tumors and Angiosarcomas (10 papers). Ciara M. Kelly is often cited by papers focused on Sarcoma Diagnosis and Treatment (22 papers), CAR-T cell therapy research (15 papers) and Vascular Tumors and Angiosarcomas (10 papers). Ciara M. Kelly collaborates with scholars based in United States, Ireland and Italy. Ciara M. Kelly's co-authors include Armin Shahrokni, Ping Chi, Yelena Y. Janjigian, Andrea Cercek, Megan Greally, William D. Tap, Sandra P. D’Angelo, Mrinal M. Gounder, Mark A. Dickson and Li‐Xuan Qin and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Clinical Cancer Research.

In The Last Decade

Ciara M. Kelly

58 papers receiving 1.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The management of metastatic GIST: current standard and investigational therapeutics

2021 144 citations Ciara M. Kelly, Ping Chi et al. Journal of Hematology & Oncology profile →

Peers

Ciara M. Kelly

ONCOL

PRM

SURGE

GASTR

Darrin Despain United States

Riccardo Valli Italy

Cristian Lolli Italy

Javier Martínez‐Trufero Spain

Shuangmei Zou China

Yusuke Onozawa Japan

Hironaga Satake Japan

Sophie Cousin France

Fausto Barbieri Italy

Isabel Sevilla Spain

Darrin Despain United States

Ciara M. Kelly

322 ×0.6

ONCOL

704 ×1.4

PRM

157 ×0.9

SURGE

45 ×0.3

GASTR

172 ×1.3

Citations per year, relative to Ciara M. Kelly Ciara M. Kelly (= 1×) peers Darrin Despain

Countries citing papers authored by Ciara M. Kelly

Since Specialization

Citations

This map shows the geographic impact of Ciara M. Kelly's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ciara M. Kelly with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ciara M. Kelly more than expected).

Fields of papers citing papers by Ciara M. Kelly

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ciara M. Kelly. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ciara M. Kelly. The network helps show where Ciara M. Kelly may publish in the future.

Co-authorship network of co-authors of Ciara M. Kelly

This figure shows the co-authorship network connecting the top 25 collaborators of Ciara M. Kelly. A scholar is included among the top collaborators of Ciara M. Kelly based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ciara M. Kelly. Ciara M. Kelly is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Bartlett, Edmund K., Nigel P. Barker, Charlotte E. Ariyan, et al.. (2025). Outcomes of Patients Undergoing Sentinel Lymph Node Biopsy for Merkel Cell Carcinoma. Annals of Surgical Oncology.

Bradić, Martina, Barbara O’Malley, Irina Linkov, et al.. (2025). Immunologic correlates in a CIC::DUX4 fusion-positive sarcoma responsive to dual immune checkpoint blockade. npj Precision Oncology. 9(1). 85–85.

Kelly, Ciara M., Mary Louise Keohan, Jason E. Chan, et al.. (2024). 1752P A retrospective single-center study of outcomes to immune checkpoint blockade-based therapy in leiomyosarcoma. Annals of Oncology. 35. S1045–S1045. 1 indexed citations

Ignatiadis, Michail, Emmanouil Saloustros, Ciara M. Kelly, et al.. (2024). 338TiP EORTC-2129-BCG: Elacestrant for treating ER+/HER2- breast cancer patients with ctDNA relapse (TREAT ctDNA). Annals of Oncology. 35. S355–S356. 2 indexed citations

Dickson, Mark A., Sujana Movva, Ciara M. Kelly, et al.. (2024). 1720MO A phase II study of palbociclib combined with the PD-1 inhibitor retifanlimab in patients with advanced dedifferentiated liposarcoma. Annals of Oncology. 35. S1031–S1031. 4 indexed citations

Deshmukh, Shriya, Ciara M. Kelly, & Gabriel Tinoco. (2024). IDH1/2 Mutations in Cancer: Unifying Insights and Unlocking Therapeutic Potential for Chondrosarcoma. Targeted Oncology. 20(1). 13–25. 1 indexed citations

Dermawan, Josephine K., Ciara M. Kelly, Zhidong Gao, et al.. (2023). Novel Genomic Risk Stratification Model for Primary Gastrointestinal Stromal Tumors (GIST) in the Adjuvant Therapy Era. Clinical Cancer Research. 29(19). 3974–3985. 13 indexed citations

Rosenbaum, Evan, Kenneth Seier, Martina Bradić, et al.. (2023). Immune-related Adverse Events after Immune Checkpoint Blockade–based Therapy Are Associated with Improved Survival in Advanced Sarcomas. Cancer Research Communications. 3(10). 2118–2125. 6 indexed citations

Dermawan, Josephine K., Abhinita Mohanty, Ivelise Rijo, et al.. (2023). Distinct IDH1/2-associated Methylation Profile and Enrichment of TP53 and TERT Mutations Distinguish Dedifferentiated Chondrosarcoma from Conventional Chondrosarcoma. Cancer Research Communications. 3(3). 431–443. 13 indexed citations

10.

Kelly, Ciara M., et al.. (2022). Thrombotic Microangiopathy Associated With Use of Liposomal Doxorubicin. Journal of the American Society of Nephrology. 33(11S). 384–384.

11.

Lee, Anna, Jung Julie Kang, Kathryn E. Marqueen, et al.. (2021). Proton radiotherapy for recurrent or metastatic sarcoma with palliative quad shot. Cancer Medicine. 10(13). 4221–4227. 7 indexed citations

12.

Kelly, Ciara M., et al.. (2021). The management of metastatic GIST: current standard and investigational therapeutics. Journal of Hematology & Oncology. 14(1). 2–2. 144 indexed citations breakdown →

13.

Rosenbaum, Evan, Kenneth Seier, Chaitanya Bandlamudi, et al.. (2020). HLA Genotyping in Synovial Sarcoma: Identifying HLA-A*02 and Its Association with Clinical Outcome. Clinical Cancer Research. 26(20). 5448–5455. 12 indexed citations

14.

Klemen, Nicholas D., Ciara M. Kelly, & Edmund K. Bartlett. (2020). The emerging role of immunotherapy for the treatment of sarcoma. Journal of Surgical Oncology. 123(3). 730–738. 16 indexed citations

15.

Zhu, Guo, Khédoudja Nafa, Narasimhan P. Agaram, et al.. (2019). Genomic Profiling Identifies Association of IDH1/IDH2 Mutation with Longer Relapse-Free and Metastasis-Free Survival in High-Grade Chondrosarcoma. Clinical Cancer Research. 26(2). 419–427. 59 indexed citations

16.

Greally, Megan, Ciara M. Kelly, & Andrea Cercek. (2018). HER2: An emerging target in colorectal cancer. Current Problems in Cancer. 42(6). 560–571. 72 indexed citations

17.

Kelly, Ciara M., Alexander N. Shoushtari, Li‐Xuan Qin, et al.. (2018). A phase Ib study of BGJ398, a pan-FGFR kinase inhibitor in combination with imatinib in patients with advanced gastrointestinal stromal tumor. Investigational New Drugs. 37(2). 282–290. 36 indexed citations

18.

Shiuan, Eileen, Kathryn E. Beckermann, Alpaslan Özgün, et al.. (2017). Thrombocytopenia in patients with melanoma receiving immune checkpoint inhibitor therapy. Journal for ImmunoTherapy of Cancer. 5(1). 8–8. 103 indexed citations

19.

Kelly, Ciara M. & Yelena Y. Janjigian. (2016). The genomics and therapeutics of HER2-positive gastric cancer—from trastuzumab and beyond. Journal of Gastrointestinal Oncology. 7(5). 750–762. 47 indexed citations

20.

Kelly, Ciara M. & Armin Shahrokni. (2016). From Shelf to Bedside—Wearable Electronic Activity Monitoring Technologies Might Assist Oncologists in Functional Performance Status Assessment of Older Cancer Patients. Clinical Colorectal Cancer. 16(2). e115–e118. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact